NYSE : MED

Medifast, Inc. — Financial statements

Consumer Discretionary · Personal Services · United States

Last price 12.15 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 126.42M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Medifast, Inc. (MED) reported revenue of 299.57M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue299.57M385.79M602.46M1.07B1.60B1.53B
Cost of Revenue92.24M110.60M157.84M296.20M458.16M398.49M
Gross Profit207.33M275.19M444.62M775.85M1.14B1.13B
Selling, General & Admin236.22M285.10M424.64M644.85M951.11M906.96M
Research & Development5.90M4.30M4.60M4.60M4.50M4.40M
Operating Expenses242.12M289.40M429.24M649.45M955.61M911.36M
Operating Income-34.78M-14.21M15.38M126.40M184.81M216.24M
Interest Expense-701.00K-231.00K
Interest & Investment Income5.65M5.52M4.80M2.49M
Other Non Operating Income (Expenses)-20.00K3.06M-3.90M-95.00K-46.00K119.00K
EBT Excluding Unusual Items-29.15M-5.64M16.29M128.80M184.06M216.13M
Merger & Restructuring Charges-12.50M
Pretax Income-29.15M-5.64M3.79M128.80M184.06M216.13M
Income Tax Expense11.70M13.03M1.70M29.38M40.49M52.10M
Earnings From Continuing Operations-40.85M-18.67M2.09M99.42M143.57M164.03M
Net Income-40.85M-18.67M2.09M99.42M143.57M164.03M
Net Income to Common-40.85M-18.67M2.09M99.42M143.57M164.03M
Shares Outstanding (Basic)11.08M10.98M10.93M10.88M11.20M11.71M
Shares Outstanding (Diluted)11.08M10.98M10.96M10.92M11.28M11.81M
EPS (Basic)-3.69-1.700.199.1312.8214.01
EPS (Diluted)-3.69-1.700.199.1012.7313.89
Free Cash Flow-3.87M1.25M17.02M141.17M177.89M60.34M
Free Cash Flow Per Share-0.350.111.5512.9315.785.11
Dividend Per Share4.956.565.68
Gross Margin69.21%71.33%73.80%72.37%71.34%73.89%
Operating Margin-11.61%-3.68%2.55%11.79%11.56%14.17%
Profit Margin-13.64%-4.84%0.35%9.27%8.98%10.75%
Free Cash Flow Margin-1.29%0.32%2.83%13.17%11.13%3.95%
EBITDA-22.03M29.00K28.09M139.51M195.79M223.05M
EBITDA Margin-7.35%0.01%4.66%13.01%12.25%14.62%
D&A For EBITDA12.76M14.24M12.71M13.11M10.98M6.81M
EBIT-34.78M-14.21M15.38M126.40M184.81M216.24M
EBIT Margin-11.61%-3.68%2.55%11.79%11.56%14.17%
Effective Tax Rate44.79%22.81%22.00%24.10%
Advertising Expenses7.50M14.10M3.40M1.70M1.60M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents58.37M89.30M90.93M94.44M87.69M104.18M
Short-Term Investments114.16M77.97M71.42M55.60M5.36M
Cash & Short-Term Investments172.53M167.27M162.34M150.04M87.69M109.54M
Inventory21.20M20.23M42.42M54.59M118.86M180.04M
Prepaid Expenses4.03M9.07M9.64M10.67M16.24M16.33M
Other Current Assets4.17M5.12M8.73M945.00K
Total Current Assets201.94M201.68M214.40M224.03M222.78M306.87M
Property, Plant & Equipment32.74M38.46M48.68M67.11M75.64M80.59M
Long-Term Deferred Tax Assets11.46M4.12M5.33M4.40M
Other Long-Term Assets5.08M7.83M9.67M14.65M12.46M6.47M
Total Assets239.76M247.97M284.21M309.91M316.21M398.33M
Accounts Payable38.80M38.36M56.49M39.19M53.12M70.89M
Accrued Expenses36.48M49.02M67.18M
Current Portion of Leases3.08M4.60M6.18M5.88M5.78M6.52M
Current Income Taxes Payable1.49M428.00K
Current Unearned Revenue574.00K7.36M8.05M
Other Current Liabilities10.17M25.19M17.19M
Total Current Liabilities41.88M42.96M64.16M92.30M140.89M169.83M
Long-Term Leases17.61M6.09M9.94M16.13M20.27M26.02M
Total Liabilities59.49M49.05M74.10M108.43M161.17M195.85M
Common Stock11.00K11.00K11.00K11.00K11.00K12.00K
Additional Paid-In Capital45.15M40.41M33.14M26.57M21.55M12.02M
Retained Earnings135.54M158.27M176.78M174.65M139.85M190.33M
Treasury Stock-6.40M
Comprehensive Income & Other-417.00K234.00K180.00K248.00K24.00K111.00K
Shareholders' Equity180.28M198.92M210.11M201.48M155.04M202.47M
Total Liabilities & Equity239.76M247.97M284.21M309.91M316.21M398.33M
Total Debt20.68M10.69M16.12M22.01M26.05M32.54M
Net Cash (Debt)151.85M156.58M146.22M128.03M61.64M77.00M
Net Cash Per Share13.7114.2613.3411.725.476.52
Filing Date Shares Outstanding10.40M10.31M10.66M10.78M10.78M11.50M
Total Common Shares Outstanding10.40M10.31M10.66M10.78M10.81M11.55M
Working Capital160.06M158.72M150.24M131.73M81.89M137.03M
Book Value Per Share17.3319.2919.7118.6914.3417.53
Tangible Book Value180.28M198.92M210.11M201.48M155.04M202.47M
Tangible Book Value Per Share17.3319.2919.7118.6914.3417.53
Land345.00K345.00K565.00K565.00K565.00K
Buildings21.73M21.35M24.50M25.91M23.52M
Machinery46.15M44.97M50.44M49.38M42.85M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-40.85M-18.67M2.09M99.42M143.57M164.03M
Depreciation & Amortization12.76M14.24M12.71M13.11M10.98M6.81M
Loss (Gain) From Sale of Assets-1.39M1.37M89.00K1.17M2.13M2.00K
Asset Writedown & Restructuring Costs10.83M
Loss (Gain) From Sale of Investments-657.00K-4.00M3.19M-319.00K14.00K89.00K
Stock-Based Compensation7.74M7.64M7.36M8.19M11.05M9.90M
Other Operating Activities16.77M16.08M8.78M5.82M5.17M1.35M
Change in Inventory2.00M22.19M12.17M64.27M61.19M-126.65M
Change in Accounts Payable-7.24M-23.91M-34.99M-35.71M-37.59M54.38M
Change in Income Taxes209.00K-6.60M10.21M-9.15M1.37M-945.00K
Change in Other Net Operating Assets-192.00K-1.48M2.87M873.00K-3.31M-14.43M
Operating Cash Flow-26.00K6.86M24.48M147.66M194.57M94.55M
Capital Expenditures-3.84M-5.61M-7.45M-6.48M-16.68M-34.21M
Sale of Property, Plant & Equipment3.64M
Investment in Securities-39.93M-2.31M-19.07M-54.56M5.27M5.14M
Investing Cash Flow-40.14M-7.93M-26.52M-61.05M-11.41M-29.06M
Issuance of Common Stock36.00K188.00K811.00K
Repurchase of Common Stock-824.00K-369.00K-836.00K-6.96M-127.96M-62.09M
Common Dividends Paid-170.00K-195.00K-715.00K-73.02M-71.62M-63.86M
Financing Cash Flow-994.00K-564.00K-1.51M-79.79M-199.58M-125.13M
Foreign Exchange Rate Adjustments4.00K4.00K47.00K-72.00K-67.00K112.00K
Net Cash Flow-41.15M-1.62M-3.51M6.75M-16.49M-59.54M
Free Cash Flow-3.87M1.25M17.02M141.17M177.89M60.34M
Free Cash Flow Margin-1.29%0.32%2.83%13.17%11.13%3.95%
Free Cash Flow Per Share-0.350.111.5512.9315.785.11
Levered Free Cash Flow-2.61M5.41M15.72M106.22M154.46M35.66M
Unlevered Free Cash Flow-2.61M5.41M15.72M106.22M154.89M35.81M
Cash Income Tax Paid672.00K10.46M-1.62M34.26M37.21M56.76M
Change in Working Capital-5.22M-9.80M-9.74M20.28M21.65M-87.65M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization126.42M109.76M187.69M724.40M1.25B2.42B
Enterprise Value-25.43M-51.49M35.36M588.99M1.21B2.28B
Last Close Price12.1510.6817.6267.22109.01188.97
PE Ratio89.767.298.7314.78
Forward PE53.7738.0013.059.0313.75
PS Ratio0.420.280.310.680.781.59
PB Ratio0.700.550.893.608.0811.97
P/TBV Ratio0.700.550.893.608.0811.97
P/FCF Ratio87.8811.035.137.0440.17
P/OCF Ratio15.997.674.916.4425.64
PEG Ratio0.550.550.550.550.55
EV/Sales Ratio0.060.550.761.50
EV/EBITDA Ratio1.264.226.1910.24
EV/EBIT Ratio2.304.666.5510.56
EV/FCF Ratio2.084.176.8137.85
Debt / Equity Ratio0.120.050.080.110.170.16
Debt / EBITDA Ratio2.170.490.150.130.14
Debt / FCF Ratio8.560.950.160.150.54
Net Debt / Equity Ratio-0.84-0.79-0.70-0.64-0.40-0.38
Net Debt / EBITDA Ratio6.89-5,399.28-5.21-0.92-0.32-0.34
Net Debt / FCF Ratio39.25-125.36-8.59-0.91-0.35-1.28
Asset Turnover1.181.452.033.424.474.53
Inventory Turnover4.153.533.253.423.073.41
Quick Ratio4.123.892.531.630.620.65
Current Ratio4.824.693.342.431.581.81
Return on Equity (ROE)-20.69%-9.13%1.02%55.77%80.31%91.20%
Return on Assets (ROA)-8.56%-3.34%3.24%25.24%32.33%40.08%
Return on Invested Capital (ROIC)-84.22%-26.76%12.37%116.95%131.72%130.80%
Return on Capital Employed (ROCE)-17.60%-6.90%7.00%58.10%105.40%94.60%
Earnings Yield-30.38%-17.01%1.11%13.72%11.46%6.77%
FCF Yield-3.06%1.14%9.07%19.49%14.19%2.49%
Dividend Yield7.37%5.66%2.71%
Payout Ratio34.19%73.45%49.89%38.93%
Buyback Yield / Dilution-0.94%-0.16%-0.39%3.15%4.55%0.31%
Total Shareholder Return-0.94%-0.16%-0.39%10.52%10.21%3.02%